1332075-40-7
1332075-40-7
Chemical Structure
Tirofiban-d9
Synonym(s): L700462-d9;MK383-d9
- CAS No.: 1332075-40-7
- Formula:C22H27D9N2O5S
- Molecular Weight:449.65
IUPAC Name: (S)-2-((butyl)sulfonamido-1,1,2,2,3,3,4,4,4-d9)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid
InChIKey: COKMIXFXJJXBQG-WVBHPKOCSA-N
SMILES: O=S(N[C@H](C(O)=O)CC1=CC=C(C=C1)OCCCCC2CCNCC2)(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O
Biological Activity: Tirofiban-d9 is deuterium labeled Tirofiban.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tirofiban-d9 | Tirofiban-d9 is deuterium labeled Tirofiban. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tirofiban (Standard) | ≥98% | Tirofiban (Standard) is the analytical standard of Tirofiban. This product is intended for research and analytical applications. Tirofiban (L700462) is a selective and reversible platelet integrin receptor (Gp IIb/IIIa) antagonist that inhibits fibrinogen binding to this receptor and has antithrombotic activity. Tirofiban induces proliferation and migration on endothelial cell by inducing production of VEGF. Tirofiban can significantly reduces myocardial no-reflow and ischemia-reperfusion injury by alleviating myocardial microvascular structural and endothelial dysfunction in the ischemic area. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tirofiban | 99.95% | Tirofiban (L700462) is a selective and reversible platelet integrin receptor (Gp IIb/IIIa) antagonist that inhibits fibrinogen binding to this receptor and has antithrombotic activity. Tirofiban induces proliferation and migration on endothelial cell by inducing production of VEGF. Tirofiban can significantly reduces myocardial no-reflow and ischemia-reperfusion injury by alleviating myocardial microvascular structural and endothelial dysfunction in the ischemic area. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
